At the Milken Institute’s Future of Health Summit, NACDS CEO Steven Anderson discussed expanding pharmacy-based support for GLP-1 patients.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.